A.M. Mandard
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Oncology top 1%
- Colorectal Cancer Surgical Treatments
- Vascular Tumors and Angiosarcomas
- Cancer-related Molecular Pathways
Papers in
-
- Sarcoma Diagnosis and Treatment 11
- Lung Cancer Treatments and Mutations 4
- Oncology 13
- Vascular Tumors and Angiosarcomas 6
- Co-authors
- P Ségol (5 shared papers)M Gignoux (4 shared papers)J. Marnay (9 shared papers)M. Henry‐Amar (7 shared papers)J.-C. Mandard (8 shared papers)A Roussel (2 shared papers)G Samama (1 shared paper)Sylvie Bonvalot (1 shared paper)
- Journals
- Cancer (5 papers)Journal of Clinical Oncology (3 papers)Cytometry (3 papers)Annals of Oncology (3 papers)Endoscopy (2 papers)
- Partner nations
- FranceLuxembourgNetherlands
In The Last Decade
A.M. Mandard
48 papers receiving 5.3k citations
A.M. Mandard's Hit Papers
Peers
Comparison fields: 5 of 104
- Pulmonary and Respiratory Medicine 2.4k
- Oncology 1.8k
- Surgery 2.2k
- Gastroenterology 132
- Cancer Research 345
Countries citing papers authored by A.M. Mandard
This map shows the geographic impact of A.M. Mandard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Mandard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Mandard more than expected).
Fields of papers citing papers by A.M. Mandard
This network shows the impact of papers produced by A.M. Mandard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Mandard. The network helps show where A.M. Mandard may publish in the future.
Co-authors
The 25 scholars most cited alongside A.M. Mandard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Hit paper breakdown → | 1994 | 1610 |
| 2 | Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus Hit paper breakdown → | 1997 | 1026 |
| 3 | Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. Hit paper breakdown → | 1997 | 647 |
| 4 | Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. Hit paper breakdown → | 1996 | 487 |
| 5 | 2000 | 177 | |
| 6 | 1981 | 173 | |
| 7 | Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. | 1991 | 172 |
| 8 | 1998 | 144 | |
| 9 | 1996 | 135 | |
| 10 | 1989 | 133 | |
| 11 | Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers. | 1988 | 115 |
| 12 | 1999 | 78 | |
| 13 | 1994 | 58 | |
| 14 | 1980 | 47 | |
| 15 | 1991 | 47 | |
| 16 | 1984 | 40 | |
| 17 | 1986 | 38 | |
| 18 | 1978 | 35 | |
| 19 | [Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology]. | 1996 | 33 |
| 20 | 1983 | 32 |
About A.M. Mandard
A.M. Mandard is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Pathology and Forensic Medicine and Molecular Biology, having authored 48 papers that have together received 5.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (11 papers), Esophageal Cancer Research and Treatment (11 papers), Vascular Tumors and Angiosarcomas (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Cardiac tumors and thrombi (4 papers), Esophageal and GI Pathology (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.4k citations), Oncology (1.8k citations), Surgery (2.2k citations), Gastroenterology (132 citations) and Cancer Research (345 citations). A.M. Mandard has collaborated with scholars based in France, Luxembourg and Netherlands. Frequent co-authors include P Ségol, M Gignoux, J. Marnay, M. Henry‐Amar, J.-C. Mandard, A Roussel, G Samama, Sylvie Bonvalot, Jean François Petiot and V Le Doussal. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Cytometry, Annals of Oncology and Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.